Aeterna Zentaris to Present at Upcoming Piper Jaffray and Oppenheimer Healthcare Conferences in New York

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, Nov. 21, 2011 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that it will be\n presenting a Company overview at the two following healthcare\n conferences in New York City:\n\n\n23rd Annual Piper Jaffray Health Care ConferenceWednesday, November 30, 2011 at 12:30 p.m. (eastern)\nNew York Palace Hotel, New York City\n\n\nOppenheimer 22nd Annual Healthcare ConferenceTuesday, December 13, 2011 at 2:10 p.m. (eastern)\nWest Foyer Room, Waldorf-Astoria Hotel, New York City\n\n\nA live webcast of the Oppenheimer Healthcare Conference presentation\n will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris Inc.\n\n\nAeterna Zentaris is a late-stage oncology drug development company\n currently investigating potential treatments for various cancers\n including colorectal, multiple myeloma, endometrial, ovarian, prostate\n and bladder cancer. The Company's innovative approach of \"personalized\n medicine\" means tailoring treatments to a patient's specific condition\n and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn\n from its proprietary discovery unit providing the Company with constant\n and long-term access to state-of-the-art therapeutic options. For more\n information please visit www.aezsinc.com\n\n Investor Relations       Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] Chad Rubin Vice President The Trout Group LLC (646) [email protected] \n","length":2184,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.